FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis
Abstract Background Acute pancreatitis (AP) presents a significant clinical challenge with limited therapeutic options. The complex etiology and pathophysiology of AP emphasize the need for innovative treatments. This study explores mRNA-based therapies delivering fibroblast growth factor 21 (FGF21)...
Saved in:
Main Authors: | Amaya Lopez-Pascual, Eva Santamaria, Nuria Ardaiz, Iker Uriarte, Tiffany Palmer, Anne-Renee Graham, Celia Gomar, Roberto C. Barbero, M. Ujue Latasa, Maria Arechederra, Jesus M. Urman, Carmen Berasain, Antonio Fontanellas, Carlos L. del Rio, Maite G. Fernandez-Barrena, Paolo G.V. Martini, Joshua R. Schultz, Pedro Berraondo, Matias A. Avila |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-025-06129-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose-dependent effects of Nrf2 on the epidermis in chronic skin inflammation
by: Michael Koch, et al.
Published: (2025-01-01) -
Pain in pancreatitis: issue and ways out
by: A. V. Okhlobystin
Published: (2012-02-01) -
Impact of Order Set on Exocrine Pancreatic Insufficiency in Chronic Pancreatitis, Pancreatic Cancer, and Pancreatic Resection
by: Michael Ladna, et al.
Published: (2025-01-01) -
Etiopathogenic Considerations of Alcohol in Pancreatitis
by: Leonardo Javier Pérez Ponce, et al.
Published: (2017-02-01) -
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma
by: Daniel Oyon, et al.
Published: (2025-01-01)